Form 8-K - Current report:
SEC Accession No. 0001528287-21-000017
Filing Date
2021-11-10
Accepted
2021-11-10 16:06:12
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K npce-20211110.htm   iXBRL 8-K 35091
2 EX-99.1 exhibit991_q32021earningsr.htm EX-99.1 75846
6 GRAPHIC nps_logoxweb-rgba.gif GRAPHIC 5868
  Complete submission text file 0001528287-21-000017.txt   268352

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT npce-20211110.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT npce-20211110_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT npce-20211110_pre.xml EX-101.PRE 13037
7 EXTRACTED XBRL INSTANCE DOCUMENT npce-20211110_htm.xml XML 11692
Mailing Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043 6502372700
NeuroPace Inc (Filer) CIK: 0001528287 (see all company filings)

EIN.: 223550230 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40337 | Film No.: 211396538
SIC: 3841 Surgical & Medical Instruments & Apparatus